EMA shortages Shortage resolved Medicine shortages
Fabrazyme — supply shortage (shortage resolved)
Published by European Medicines Agency:
Summary
Supply shortage
Medicine
Fabrazyme
- Category
- Medicine shortages
- Product type
- Human medicine
- Active substance (INN): agalsidase beta
- Therapeutic area: Fabry Disease
- Pharmaceutical forms affected: Powder for concentrate for solution for infusion
- Strengths affected: 5 mg;35 mg
- Last updated: 07/06/2016
Measures and alternatives
- Availability of alternatives: No
Source: EMA — medicine shortages — European Medicines Agency
Source: European Medicines Agency (EMA). Reproduced with acknowledgement of the source, in line with the EMA legal notice. EU Safety Radar is an independent information service; the text above presents the official data in the original language — the notice published by the authority is authoritative.
Open the original notice (www.ema.europa.eu) ↗